-+ 0.00%
-+ 0.00%
-+ 0.00%

DUPIXENT® (DUPILUMAB) DATA AT REVOLUTIONIZING ATOPIC DERMATITIS (RAD) CONFERENCE REINFORCE USE IN ATOPIC DERMATITIS PATIENTS WITH SKIN OF COLOR

Reuters·06/07/2025 22:30:03

Please log in to view news